help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xiao, C. W.
Right arrow Articles by Tsang, B. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiao, C. W.
Right arrow Articles by Tsang, B. K.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CYCLOHEXIMIDE
Medline Plus Health Information
*Ovarian Cancer
Endocrinology Vol. 144, No. 2 623-630
Copyright © 2003 by The Endocrine Society


ARTICLE

Resistance of Human Ovarian Cancer Cells to Tumor Necrosis Factor {alpha} Is a Consequence of Nuclear Factor {kappa}B-Mediated Induction of Fas-Associated Death Domain-Like Interleukin-1ß-Converting Enzyme-Like Inhibitory Protein

Chao Wu Xiao, Xiaojuan Yan, Yulian Li, Shrikanth A. G. Reddy and Benjamin K. Tsang

Department of Obstetrics and Gynecology and Cellular and Molecular Medicine (C.W.X., X.Y., Y.L., B.K.T.), Reproductive Biology Unit and Division of Gynecologic Oncology, University of Ottawa, Ottawa Health Research Institute, The Ottawa Hospital, Ottawa, Ontario, Canada K1Y 4E9; Nutrition Research Division (C.W.X.), Food Directorate, Health Products and Food Branch, Health Canada, Banting Research Centre, Ottawa, Ontario, Canada K1A 0L2; Department of GI Oncology and Digestive Diseases (S.A.G.R.), Division of Medicine, M. D. Anderson Cancer Center, University of Texas, Houston, Texas 77030

Address all correspondence and requests for reprints to: Dr. Benjamin K. Tsang, Ottawa Health Research Institute, The Ottawa Hospital (Civic Campus), 725 Parkdale Avenue, Ottawa, Ontario, Canada K1Y 4E9. E-mail: btsang{at}ohri.ca.

The purpose of the present studies was to examine the role and regulation of Fas-associated death domain-like IL-1- converting enzyme-like inhibitory protein [FLIP; long (FLIPL) and short (FLIPS) forms] in human ovarian epithelial cancer cells by TNF{alpha} and their significance in the resistance of the cells to the proapoptotic action of the cytokine. OV2008, A2780-s, and OVCAR-3 cells were cultured in serum-free media with or without cycloheximide (CHX, 10 µg/ml) ± TNF{alpha} (5, 10, 20 ng/ml) or transfected with a mammalian expression vector containing either a dominant negative inhibitor {kappa}B (I{kappa}B), FLIPS sense or antisense cDNA and cultured with or without TNF{alpha}. In the presence of CHX, TNF{alpha} increased caspase-8 and -3 cleavage and apoptosis. It also induced I{kappa}B phosphorylation, nuclear factor {kappa}B activation, and the expression of FLIPS but not of FLIPL. Overexpression of dominant negative I{kappa}B attenuated TNF{alpha}-induced FLIPS expression and enhanced TNF{alpha}-induced apoptosis. Apoptosis induced by TNF{alpha} and CHX was facilitated by FLIPS antisense expression but attenuated by sense transfection. This study demonstrates that TNF{alpha} up-regulates FLIPS expression, and this effect is mediated by the activation of nuclear factor {kappa}B. The induction of FLIPS expression by TNF{alpha} might contribute to the resistance of ovarian epithelial cancer cells to the proapoptotic action of the cytokine.




This article has been cited by other articles:


Home page
EndocrinologyHome page
C. Van Themsche, L. Lafontaine, and E. Asselin
X-Linked Inhibitor of Apoptosis Protein Levels and Protein Kinase C Activity Regulate the Sensitivity of Human Endometrial Carcinoma Cells to Tumor Necrosis Factor{alpha}-Induced Apoptosis
Endocrinology, August 1, 2008; 149(8): 3789 - 3798.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. R. Abedini, E. J. Muller, J. Brun, R. Bergeron, D. A. Gray, and B. K. Tsang
Cisplatin Induces p53-Dependent FLICE-Like Inhibitory Protein Ubiquitination in Ovarian Cancer Cells
Cancer Res., June 15, 2008; 68(12): 4511 - 4517.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. F. Segura, C. Sole, M. Pascual, R. S. Moubarak, M. Jose Perez-Garcia, R. Gozzelino, V. Iglesias, N. Badiola, J. R. Bayascas, N. Llecha, et al.
The Long Form of Fas Apoptotic Inhibitory Molecule Is Expressed Specifically in Neurons and Protects Them against Death Receptor-Triggered Apoptosis
J. Neurosci., October 17, 2007; 27(42): 11228 - 11241.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. Mei, C. Wood, M. R. L'Abbe, G. S. Gilani, G. M. Cooke, I. H. Curran, and C. W. Xiao
Consumption of Soy Protein Isolate Modulates the Phosphorylation Status of Hepatic ATPase/ATP Synthase {beta} Protein and Increases ATPase Activity in Rats
J. Nutr., September 1, 2007; 137(9): 2029 - 2035.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. W. Xiao, J. Mei, W. Huang, C. Wood, M. R. L'Abbe, G. S. Gilani, G. M. Cooke, and I. H. Curran
Dietary Soy Protein Isolate Modifies Hepatic Retinoic Acid Receptor-{beta} Proteins and Inhibits Their DNA Binding Activity in Rats
J. Nutr., January 1, 2007; 137(1): 1 - 6.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
N. Muthukumaran, K. E. Miletti-Gonzalez, A. K. Ravindranath, and L. Rodriguez-Rodriguez
Tumor Necrosis Factor-{alpha} Differentially Modulates CD44 Expression in Ovarian Cancer Cells
Mol. Cancer Res., August 1, 2006; 4(8): 511 - 520.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
W. Huang, C. Wood, M. R. L'Abbe, G. S. Gilani, K. A. Cockell, and C. W. Xiao
Soy Protein Isolate Increases Hepatic Thyroid Hormone Receptor Content and Inhibits Its Binding to Target Genes in Rats
J. Nutr., July 1, 2005; 135(7): 1631 - 1635.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. Yang, J. L. Wiser, J. J. Peairs, J. N. Ebright, Z. J. Zavodni, C. Bowes Rickman, and G. J. Jaffe
Human RPE Expression of Cell Survival Factors
Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1755 - 1764.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Xu, Y. Zhong, S. Munir, B. B. Yang, B. K. Tsang, and C. Peng
Nodal Induces Apoptosis and Inhibits Proliferation in Human Epithelial Ovarian Cancer Cells via Activin Receptor-Like Kinase 7
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5523 - 5534.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
P. Yang, B. S. McKay, J. B. Allen, and G. J. Jaffe
Effect of NF-{kappa}B Inhibition on TNF-{alpha}-Induced Apoptosis in Human RPE Cells
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2438 - 2446.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M.-T. Lin, C.-C. Chang, S.-T. Chen, H.-L. Chang, J.-L. Su, Y.-P. Chau, and M.-L. Kuo
Cyr61 Expression Confers Resistance to Apoptosis in Breast Cancer MCF-7 Cells by a Mechanism of NF-{kappa}B-dependent XIAP Up-Regulation
J. Biol. Chem., June 4, 2004; 279(23): 24015 - 24023.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. W. Xiao, M. R. L'Abbe, G. S. Gilani, G. M. Cooke, I. H. Curran, and S. A. Papademetriou
Dietary Soy Protein Isolate and Isoflavones Modulate Hepatic Thyroid Hormone Receptors in Rats
J. Nutr., April 1, 2004; 134(4): 743 - 749.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. J. Waxman and P. S. Schwartz
Harnessing Apoptosis for Improved Anticancer Gene Therapy
Cancer Res., December 15, 2003; 63(24): 8563 - 8572.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
H. Wajant
Targeting the FLICE Inhibitory Protein (FLIP) in Cancer Therapy
Mol. Interv., May 1, 2003; 3(3): 124 - 127.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society